Spectrum from common postpartum blues to severe depression and rare psychosis.
Also known as: postpartum depression, PPD, postpartum psychosis, perinatal depression, baby blues
Overview
Postpartum blues: transient, mild mood symptoms in the first 2 weeks postpartum, self-limited. Postpartum (perinatal) depression: a major depressive episode with onset during pregnancy or within 12 months postpartum, lasting >=2 weeks. Postpartum psychosis: a psychiatric emergency with delusions, hallucinations, disorganized behavior, or severe mood disturbance, usually within 4 weeks of delivery.
Epidemiology
Postpartum blues: up to 80% of postpartum women. PPD: 10-15% of postpartum women. Postpartum psychosis: 1-2 per 1000 deliveries; markedly increased risk in women with bipolar disorder (up to 25-50%).
Try two board-style Postpartum Depression and Postpartum Psychosis questions
Real questions from the FirstPassPA bank, with the full explanation. Pick an answer — no signup, no email.
Question 1ReproductiveMedium
A woman has severe depression, guilt, insomnia, and poor bonding 4 weeks after delivery. She denies hallucinations or intent to harm herself or the infant. Which of the following is the most appropriate treatment?
ABenzodiazepine monotherapy as needed
BInterpersonal psychotherapy
CReassurance with six-week follow-up
DPsychotherapy plus SSRI therapy
Reveal answer & full explanation
Correct answer: D — Psychotherapy plus SSRI therapy
ABenzodiazepine monotherapy as needed
BInterpersonal psychotherapy
CReassurance with six-week follow-up
DPsychotherapy plus SSRI therapy✓
Why Psychotherapy plus SSRI therapy is correct
Postpartum depression presenting with persistent depressed mood, guilt, insomnia, and impaired bonding warrants active treatment.
Combining psychotherapy with an SSRI is standard, choosing an agent compatible with breastfeeding such as sertraline.
Absence of psychosis or harm intent keeps this in the outpatient depression pathway.
Why the others are wrong
Interpersonal psychotherapy — Psychotherapy without medication is first-line only for mild to moderate postpartum depression; severe symptoms with impaired bonding call for combined treatment (undertreatment trap).
Reassurance with six-week follow-up — Symptoms this impairing at 4 weeks exceed baby blues, which resolve within two weeks of delivery, so deferring care another six weeks is inappropriate (minimization trap).
Benzodiazepine monotherapy as needed — Benzodiazepines treat neither the core depression nor bonding impairment and risk dependence and sedation while caring for an infant (wrong-drug-class trap).
Question 2ReproductiveMedium
A 29-year-old woman presents 3 months postpartum with low mood, fatigue, poor concentration, and a 7-lb weight gain over 4 weeks. She reports she is "freezing all the time," is constipated, and feels her thinking has slowed. She denies suicidal ideation, delusions, or thoughts of harming her infant, and her PHQ-9 score is 14. On exam she is bradycardic at 54/min with dry skin and delayed relaxation of the deep tendon reflexes. Which of the following is the most appropriate next diagnostic test?
AEdinburgh Postnatal Depression Scale
BSerum thyroid-stimulating hormone
CUrine toxicology and drug screen
DSerum cortisol with ACTH stimulation
Reveal answer & full explanation
Correct answer: B — Serum thyroid-stimulating hormone
AEdinburgh Postnatal Depression Scale
BSerum thyroid-stimulating hormone✓
CUrine toxicology and drug screen
DSerum cortisol with ACTH stimulation
Why Serum thyroid-stimulating hormone is correct
Postpartum mood symptoms overlap heavily with postpartum thyroiditis, which classically follows transient hyperthyroidism with a hypothyroid phase 4-8 months postpartum.
This patient's cold intolerance, constipation, weight gain, bradycardia, dry skin, and delayed-relaxation (hung-up) reflexes point to hypothyroidism, a common and treatable mimic of postpartum depression.
Guidelines (ACOG) advise checking TSH and free T4 in any postpartum patient with mood symptoms before attributing them solely to a primary mood disorder, because untreated thyroid dysfunction will blunt the response to antidepressants.
Why the others are wrong
Edinburgh Postnatal Depression Scale is a validated screen for perinatal depression, but it only quantifies mood symptoms and cannot identify the organic cause suggested by this patient's bradycardia, dry skin, and hung-up reflexes.
Urine toxicology and drug screen is appropriate only when substance use is clinically suspected; nothing here ties the symptoms to drug use, and it would not explain the hypothyroid physical findings.
Serum cortisol with ACTH stimulation evaluates Sheehan syndrome or adrenal insufficiency, which present with failure to lactate, hypotension, and a postpartum hemorrhage history, none of which this normotensive patient has.
🔒 Free preview limit reached
Keep reading — start your free trial
You've read your 2 free diagnosis previews. Create your free account to unlock the full Postpartum Depression and Postpartum Psychosis outline — plus all 514 diagnoses, 6,500+ board-style questions, flashcards, and an AI tutor. Your 7-day free trial includes everything, and there's no credit card required.
Multifactorial — abrupt drop in estrogen and progesterone after delivery, HPA-axis dysregulation, inflammatory cytokines, sleep deprivation, and genetic vulnerability. Postpartum psychosis is now considered closely related to bipolar disorder.
Clinical presentation
Symptoms
Depression: depressed mood, anhedonia, sleep/appetite changes, guilt, fatigue, poor concentration, suicidal ideation; may include obsessive thoughts of harming the baby (ego-dystonic, usually no intent to act)
Psychosis: rapid onset (often first 2 wk) of insomnia, irritability, mood swings, paranoia, hallucinations, delusions (often involving the infant), confusion, disorganization
Difficulty bonding with the infant; thoughts of self-harm or harming the infant
Primary psychotic disorder — Pre-existing schizophrenia; onset not specifically perinatal
Diagnostic workup
Diagnostic criteria
DSM-5-TR: major depressive episode with peripartum-onset specifier (onset during pregnancy or within 4 weeks postpartum; in practice screening covers up to 12 mo). Edinburgh Postnatal Depression Scale (EPDS, cutoff >=10) or PHQ-9 used for screening. Postpartum psychosis: criteria for brief psychotic disorder or bipolar/mood disorder with psychotic features and peripartum onset.
Labs
TSH and free T4 (postpartum thyroiditis)
CBC (anemia), CMP, vitamin D, vitamin B12
Toxicology if clinically indicated
Imaging
Neuroimaging if focal findings, severe headache, or first psychotic episode without explanation
Diagnostic algorithm
Condition
Onset
Duration
Key Features
Treatment
Postpartum blues
Day 2-5
<=2 weeks
Mild lability, tearfulness; no impairment
Reassurance, support, observation
Postpartum depression
Within 12 mo (often <3 mo)
>=2 weeks
Depressed mood, anhedonia, +/- intrusive thoughts
Psychotherapy +/- SSRI (sertraline); brexanolone/zuranolone in severe
Psychiatric emergency, admit, mood stabilizer + antipsychotic, ECT for refractory
Spectrum of postpartum mood disorders.
Treatment
First-line
Universal screening for perinatal depression at the initial OB visit, at least once during pregnancy, at the postpartum visit, and at well-child visits (USPSTF, ACOG, AAP)
Moderate-severe PPD or with suicidal ideation: SSRI (sertraline preferred — low breast milk transfer; paroxetine alternative) + psychotherapy + safety planning
Brexanolone IV (60 h infusion) or oral zuranolone (14-day course) — FDA-approved neuroactive steroid GABA-A modulators for postpartum depression with rapid onset
Postpartum psychosis is a psychiatric emergency: immediate hospitalization, do not leave mother alone with infant, evaluate for harm to self or infant; mood stabilizer (lithium, valproate — avoid valproate if breastfeeding/women of reproductive age), atypical antipsychotic (olanzapine, risperidone), ECT considered for refractory or severe cases
Breastfeeding considerations
Sertraline and paroxetine have the lowest infant exposure
Fluoxetine has a long half-life and active metabolites — relatively higher infant levels
Lithium and valproate generally avoided during breastfeeding (lithium is acceptable with monitoring per recent guidelines)
Most antipsychotics (olanzapine, quetiapine, risperidone) compatible with breastfeeding
Second-line / adjunct
SNRI (venlafaxine, duloxetine), bupropion, mirtazapine for partial response or specific symptom profile
ECT for severe, refractory, or psychotic depression
Social support, partner involvement, sleep optimization
Complications
Maternal suicide (leading cause of postpartum maternal mortality in many high-income countries)
Infanticide (rare, predominantly in postpartum psychosis)
Family disruption, marital discord, recurrent depression
PANCE pearls
Postpartum blues do not require treatment but warrant follow-up — persistence beyond 2 weeks or impairment should prompt reassessment for PPD.
Postpartum psychosis is a psychiatric emergency. Up to 4% commit infanticide and 5% suicide if untreated — admit and never leave mother alone with infant until stabilized.
Sertraline is the preferred SSRI in lactating mothers given its minimal breast milk transfer.
Always check TSH in postpartum mood disorders — postpartum thyroiditis is common and treatable.
Bipolar disorder must be considered before starting an SSRI alone — unrecognized bipolar postpartum psychosis can be precipitated or worsened by monotherapy antidepressants.
References
ACOG CO 757 — ACOG Committee Opinion 757: Screening for Perinatal Depression (Obstet Gynecol 2018)
USPSTF 2019 — USPSTF: Interventions to Prevent Perinatal Depression (Grade B)
FDA Brexanolone — FDA approval Zulresso (brexanolone) for postpartum depression (2019); Zurzuvae (zuranolone) (2023)
Practice Reproductive questions on FirstPassPA
Turn this outline into retention. 6,500+ board-style questions with an AI tutor that explains every answer — free to start, no card required.
Educational use only. This outline is a study aid for PA students and is not medical advice or a substitute for clinical judgment. FirstPassPA is an independent study tool and is not affiliated with, endorsed by, or sponsored by NCCPA or PAEA. PANCE® and PANRE® are registered trademarks of the National Commission on Certification of Physician Assistants; End of Rotation™ is a program of the Physician Assistant Education Association.